title: RE: Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.
authors.affiliation: Affiliations of authors: Patient Blood Management, Eastern Maine Medical Center, Bangor, ME (IG); Department of hematology, Georgetown University, Baltimore, MD (MA).
authors.forename: Irwin
authors.initials: I
authors.lastname: Gross
authors.forename: Michael
authors.initials: M
authors.lastname: Auerbach
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006397:Hematinics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans
chemical_list: D006397:Hematinics; D006454:Hemoglobins; D004921:Erythropoietin